Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysis

Pathology

Volumn 44, Issue 3, 2012, Pages 204-208

  Kerger, Michael ^a,b   Hong, Matthew K H ^a,b   Pedersen, John ^c   Nottle, Timothy ^b   Ryan, Andrew ^c   Mills, John ^c   Peters, Justin S ^a,b   Moon, Daniel ^a,b   Crowe, Helen ^a,b   Costello, Anthony J ^a,b,d   Corcoran, Niall M ^a,b   Hovens, Christopher M ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b EPWORTH HOSPITAL   (Australia)

^c Tissupath Pty Ltd   (Australia)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Frozen section; Histopathology; Prostate cancer; Radical prostatectomy; Tumour annotation; Tumour biobanking

Indexed keywords

EID: 84863648298     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283511c96     Document Type: Article

References (15)

1. Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 2010; 220: 263-80.
2. Patel AA, Gilbertson JR, Parwani AV, et al. An informatics model for tissue banks - lessons learned from the Cooperative Prostate Cancer Tissue Resource. BMC Cancer 2006; 6: 120.
3. Riddick AC, Barker C, Sheriffs I, et al. Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int 2003; 91: 315-23. (Pubitemid 36359633)
4. Corcoran NM, Hong MK, Casey RG, et al. Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence. BJU Int 2011; 108: E202-210.
5. Hong MK, Namdarian B, Corcoran NM, et al. Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroup. Pathology 2011; 43: 138-42.
6. Wong KM, Hudson TJ, McPherson JD. Unraveling the genetics of cancer: genome sequencing and beyond. Annu Rev Genomics Hum Genet 2011; 12: 407-30.
7. Sastre L. New DNA sequencing technologies open a promising era for cancer research and treatment. Clin Transl Oncol 2011; 5: 301-6.
8. Ma S, Funk CC, Price ND. Systems approaches to molecular cancer diagnostics. Discov Med 2010; 55: 531-42.
9. Pfeifer GP, Hainaut P. Next-generation sequencing: emerging lessons on the origins of human cancer. Curr Opin Oncol 2011; 23: 62-8.
10. Hudson TJ, Anderson W, Artez A, et al. International Cancer Genome ConsortiumInternational network of cancer genome projects. Nature 2010; 464: 993-8.
11. Christensen GB, Baffoe-Bonnie AB, George A, et al. International Consortium for Prostate Cancer GeneticsGenome-wide linkage analysis of 1, 233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 2010; 70: 735-44.
12. Cooper L, Kong J, Gutman D, et al. An integrative approach for in silico glioma research. IEEE Trans Biomed Eng 2010; 57: 2617-21.
13. Bolton KL, Tyrer J, Song H, et al. Commonvariantsat 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010; 42: 880-4.
14. Ovaska K, Laakso M, Haapa-Paananen S, et al. Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med 2010; 2: 65.
15. Sherwin JC, Mirmilstein G, Pedersen J, Lawrentschuk N, Bolton D, Mills J. Tumour volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. J Urol 2010; 183: 1808-14.